Liquidia LQDA
NASDAQ LQDA
$68.47 +0.79 (+1.17%)
As of: Sep 9, 2026 · 1:49 PM EDT

Liquidia (LQDA) Shares Outstanding (2019 - 2026)

Liquidia (LQDA) posted Shares Outstanding (Entity) of $89.1 million for Q2 2026, up 0.9% on a QoQ basis from $88.3 million in Q1 2026, and up 3.77% year-over-year from $85.9 million in Q2 2025.

Analysis

Liquidia (LQDA) Shares Outstanding (2019 - 2026) Analysis & Trends

Liquidia has reported Shares Outstanding (Entity) for 8 years, with the latest figure at $89.1 million in Q2 2026.

  • On a quarterly basis, Shares Outstanding (Entity) rose 3.77% year-over-year to $89.1 million in Q2 2026; TTM through Jun 2026 was $89.1 million, a 3.77% increase from a year earlier, with the FY2025 full-year figure at $87.2 million, up 2.98% from the prior year.
  • Shares Outstanding (Entity) was $89.1 million for Q2 2026 at Liquidia, up from $88.3 million in the prior quarter.
  • The five-year high for Shares Outstanding (Entity) was $89.1 million in Q2 2026, with the low at $53.1 million in Q1 2022.
  • Average Shares Outstanding (Entity) over 5 years is $75.2 million, with a median of $76.4 million recorded in 2024.
  • The sharpest annual moves came in 2023 and 2024: Shares Outstanding (Entity) grew 0.61% in 2023, then soared 30.27% in 2024.
  • Over 5 years, Shares Outstanding (Entity) stood at $64.5 million in 2022, then rose by 6.37% to $68.6 million in 2023, then advanced by 23.39% to $84.7 million in 2024, then climbed by 2.98% to $87.2 million in 2025, then increased by 2.17% to $89.1 million in 2026.
  • The last three Shares Outstanding (Entity) figures came in at $89.1 million (Q2 2026), $88.3 million (Q1 2026), and $87.2 million (Q4 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Shares Outstanding (Qtr)
1 Johnson & Johnson 643.50 Bn 622.74 Bn 17.26 Bn 2.41 Bn
2 AbbVie 440.29 Bn 433.72 Bn 12.70 Bn 1.77 Bn
3 Merck 364.93 Bn 357.79 Bn 12.21 Bn 2.47 Bn
4 Novartis Ag 266.65 Bn 258.96 Bn 11.24 Bn 1.94 Bn
5 Pfizer 158.92 Bn 147.22 Bn 10.94 Bn 5.70 Bn
6 Sanofi 52.46 Bn 45.08 Bn 10.79 Bn 1.22 Bn
7 Revolution Medicines 44.32 Bn 44.32 Bn - 210.89 Mn
8 Incyte 25.32 Bn 20.78 Bn 1.57 Bn 200.38 Mn
9 United Therapeutics 21.42 Bn 18.75 Bn 683.80 Mn 42.60 Mn
10 Liquidia 6.09 Bn 5.80 Bn 160.92 Mn 88.89 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 88.89 Mn
Mar 31, 2026 88.01 Mn
Dec 31, 2025 86.06 Mn
Sep 30, 2025 86.33 Mn
Jun 30, 2025 85.59 Mn
Mar 31, 2025 85.17 Mn
Dec 31, 2024 78.71 Mn
Sep 30, 2024 78.32 Mn
Jun 30, 2024 76.44 Mn
Mar 31, 2024 75.39 Mn
Dec 31, 2023 64.99 Mn
Sep 30, 2023 64.86 Mn
Jun 30, 2023 64.79 Mn
Mar 31, 2023 64.66 Mn
Dec 31, 2022 60.96 Mn
Sep 30, 2022 64.46 Mn
Jun 30, 2022 62.18 Mn
Mar 31, 2022 52.47 Mn
Dec 31, 2021 49.68 Mn
Sep 30, 2021 52.08 Mn